Trial Profile
Rozerem 8 mg Tablets Specified Drug-use Survey: 'Long-term Survey on Insomnia Associated With Sleep-onset Difficulty ' − Transitional Survey From the Preceding Drug-use Survey −
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2016
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Adverse reactions
- Sponsors Takeda
- 01 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Jun 2014 New trial record